{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:59:20Z","timestamp":1760403560600,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijantimicag.2021.106347","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:55:22Z","timestamp":1618970122000},"page":"106347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unintentional artenimol\/piperaquine overdose in two children occurring without evidence of subsequent cardiotoxicity"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-3781","authenticated-orcid":false,"given":"Alexandra","family":"Tielli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-6316","authenticated-orcid":false,"given":"Vincent","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Pull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bouchaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Siriez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"Guidelines for the treatment of malaria","key":"10.1016\/j.ijantimicag.2021.106347_bib0001"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2875-10-50","article-title":"Safety and efficacy of dihydroartemisinin\u2013piperaquine versus artemether\u2013lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children","volume":"10","author":"Nambozi","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0003","article-title":"Four Artemisinin-Based Combinations (4ABC) Study Group. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial","volume":"8","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0004","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1128\/AAC.02682-14","article-title":"Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo","volume":"58","author":"Onyamboko","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12936-014-0521-2","article-title":"Randomized non-inferiority and safety trial of dihydroartemisin\u2013piperaquine and artesunate\u2013amodiaquine versus artemether\u2013lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children","volume":"14","author":"Nji","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0006","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12936-016-1408-1","article-title":"Impact of using artemisinin-based combination therapy (ACT) in the treatment of uncomplicated malaria from Plasmodium falciparum in a non-endemic zone","volume":"15","author":"Pousibet-Puerto","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2125.2003.01962.x","article-title":"Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria","volume":"57","author":"Karunajeewa","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0008","doi-asserted-by":"crossref","first-page":"e11880","DOI":"10.1371\/journal.pone.0011880","article-title":"An open-label, randomised study of dihydroartemisinin\u2013piperaquine versus artesunate\u2013mefloquine for falciparum malaria in Asia","volume":"5","author":"Valecha","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0009","doi-asserted-by":"crossref","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","article-title":"Dihydroartemisinin\u2013piperaquine and artemether\u2013lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial","volume":"4","author":"Bassat","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0010","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/AAC.05688-11","article-title":"In vitro cardiovascular effects of dihydroartemisin\u2013piperaquine combination compared with other antimalarials","volume":"56","author":"Borsini","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0011","doi-asserted-by":"crossref","first-page":"e02000","DOI":"10.1128\/AAC.02000-16","article-title":"Piperaquine population pharmacokinetics and cardiac safety in Cambodia","volume":"61","author":"Vanachayangkul","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"year":"2011","series-title":"Eurartesim (dihydroartemisinin\/piperaquine phosphate): public assessment report","key":"10.1016\/j.ijantimicag.2021.106347_bib0012"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003264","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","author":"Vandenberk","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002212","article-title":"Population pharmacokinetic properties of piperaquine in falciparum malaria: an individual participant data meta-analysis","volume":"14","author":"Hoglund","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12936-019-3047-9","article-title":"Artenimol\u2013piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort","volume":"18","author":"Pull","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0016","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40261-015-0312-8","article-title":"Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin","volume":"35","author":"Reuter","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ijantimicag.2021.106347_bib0017","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/11319340-000000000-00000","article-title":"Pharmacokinetic\/pharmacodynamic profile of posaconazole","volume":"49","author":"Li","year":"2010","journal-title":"Clin Pharmacokinet"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:38:42Z","timestamp":1760377122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857921000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0924857921000893"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106347","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unintentional artenimol\/piperaquine overdose in two children occurring without evidence of subsequent cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106347"}}